ART AND SCIENCE OF PHOTODYNAMIC THERAPY

10.1038/jid.1959.40

Raab O, 1900, Uber die Wirkung Fluoreszierender Stoffen auf Infusoria, Z. Biol., 39, 524

10.1096/fj.00-0555rev

Jesionek A, 1905, On the treatment of skin cancers with fluorescent substances, Arch. Klin. Med., 82, 223

10.1016/S0022-5223(19)32560-7

Schwartz SK, 1955, Some relationships of porphyrins, X‐rays and tumors, Univ. Minn. Med. Bull., 27, 7

10.1007/s101030200027

10.1002/(SICI)1097-0347(199809)20:6<556::AID-HED11>3.0.CO;2-O

Olivo M, 2003, Macro‐microscopic fluorescence of human bladder cancer using hypericin fluorescence cystoscopy and laser confocal microscopy, Int. J. Oncol., 23, 983

10.1111/j.1464-410X.2005.05508.x

10.1002/ijc.20080

10.1111/j.1749-6632.1998.tb08193.x

10.1146/annurev.physchem.47.1.555

10.1002/(SICI)1096-9101(1996)19:3<340::AID-LSM10>3.0.CO;2-8

10.1111/j.1751-1097.1998.tb02521.x

10.1364/AO.42.002436

Zheng W, 2004, Confocal endomicroscopic imaging of normal and neoplastic human tongue tissue using ALA‐induced‐PPIX fluorescence: A preliminary study, Oncol. Rep., 12, 397

10.1016/S1359-6446(99)01412-9

10.1093/jnci/90.12.889

10.1111/j.1751-1097.1991.tb02072.x

10.1016/0304-4165(84)90018-7

10.1111/j.1751-1097.1991.tb03669.x

10.1016/0959-8049(92)90080-L

Fingar VH, 1988, Modification of photodynamic therapy‐induced hypoxia by fluosol‐DA (20%) and carbogen breathing in mice, Cancer Res., 48, 3350

10.1111/j.1751-1097.1981.tb09063.x

10.1097/00006123-199603000-00025

10.1002/cncr.11708

10.1097/00130404-200203000-00009

10.1016/S1572-1000(04)00012-2

10.1007/s10103-004-0314-x

10.1001/archderm.1960.01580040026005

10.1080/09546630310012118

10.1562/0031-8655(2001)0730191PHSPTM2.0.CO2

Ferrario A, 2000, Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma, Cancer Res., 60, 4066

10.1038/359843a0

Senger DR, 1986, A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines, Cancer Res., 46, 5629

10.1111/j.1751-1097.2004.tb01265.x

10.1007/s00280-005-1017-0

10.1023/A:1006367032156

Ferrario A, 2002, Cyclooxygenase‐2 inhibitor treatment enhances photodynamic therapy‐mediated tumor response, Cancer Res., 62, 3956

10.1111/j.1365-2133.2004.06053.x

10.1111/j.1751-1097.1994.tb05140.x

10.1111/j.1751-1097.1992.tb02153.x

Du HY, 2003, Hypericin‐mediated photodynamic therapy induces lipid peroxidation and necrosis in nasopharyngeal cancer, Int. J. Oncol., 23, 1401

Agarwal ML, 1993, Phospholipase activation triggers apoptosis in photosensitized mouse lymphoma cells, Cancer Res., 53, 5897

10.1093/jnci/85.6.443

10.1016/S0022-5347(17)37370-6

10.1016/0090-4295(89)90399-3

Krosl G, 1996, Potentiation of photodynamic therapy‐elicited antitumor response by localized treatment with granulocyte‐macrophage colony‐stimulating factor, Cancer Res., 56, 3281

10.1016/1011-1344(91)80060-U

DuH BayBH MahendranR OlivoM.Hypericin‐mediated photodynamic therapy elicits differential interleukin‐6 response in nasopharyngeal cancer.Cancer Lett.2005(in press).

10.1111/j.1751-1097.1992.tb04268.x

10.1111/j.1751-1097.1992.tb02157.x

10.1016/0277-5379(90)90072-2

10.1111/j.1751-1097.1990.tb08689.x

10.1007/BF00685037

Hirpara JL, 2000, Induction of mitochondrial permeability transition and cytochrome c release in the absence of caspase activation is insufficient for effective apoptosis in human leukemia cells, Blood, 95, 1773, 10.1182/blood.V95.5.1773.005k17_1773_1780

10.1182/blood.V93.12.4096

10.1016/0277-5379(91)90276-J

10.1016/0166-3542(94)90102-3

10.1016/S1011-1344(01)00267-6

10.1016/S0168-3659(01)00491-6

10.1385/1-59259-167-1:329

10.1016/j.ophtha.2005.09.002